Primary Site >> Pancreatic Cancer
Gene >> TOP2A
| 1. | |||||||||||
| Journal: | Mod Pathol. 2003 Sep;16(9):902-12. | ||||||||||
| Title: | Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. | ||||||||||
| Author: | Maitra, Anirban|Adsay, N Volkan|Argani, Pedram|Iacobuzio-Donahue, Christine|De Marzo, Angelo|Cameron, John L|Yeo, Charles J|Hruban, Ralph H | ||||||||||
| PMID: | 13679454 | ||||||||||
| 2. | |||||||||||
| Journal: | Am J Clin Pathol. 2005 Jan;123(1):28-35. | ||||||||||
| Title: | A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment. | ||||||||||
| Author: | Hansel, Donna E|Ashfaq, Raheela|Rahman, Ayman|Wanzer, Dana|Yeo, Charles J|Wilentz, Robb E|Maitra, Anirban | ||||||||||
| PMID: | 15762277 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Cancer Ther. 2005 Sep;4(9):1338-48. | ||||||||||
| Title: | Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. | ||||||||||
| Author: | Kokkinakis, Demetrius M|Liu, Xiaoyan|Neuner, Russell D | ||||||||||
| PMID: | 16170025 | ||||||||||
| 4. | |||||||||||
| Journal: | Zhonghua Bing Li Xue Za Zhi. 2007 Feb;36(2):102-6. | ||||||||||
| Title: | [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas]. | ||||||||||
| Author: | Liang, Zhi-Yong|Wang, Wen-Ze|Gao, Jie|Wu, Sha-Fei|Zeng, Xuan|Liu, Tong-Hua | ||||||||||
| PMID: | 17493384 | ||||||||||
| 5. | |||||||||||
| Journal: | HPB (Oxford). 2007;9(2):150-5. | ||||||||||
| Title: | Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patients. | ||||||||||
| Author: | Bai, Jianfeng|Sata, Naohiro|Nagai, Hideo | ||||||||||
| PMID: | 18333132 | ||||||||||
| 6. | |||||||||||
| Journal: | World J Gastrointest Oncol. 2015 Sep 15;7(9):132-40. | ||||||||||
| Title: | Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review. | ||||||||||
| Author: | Borazanci, Erkut|Millis, Sherri Z|Korn, Ron|Han, Haiyong|Whatcott, Clifford J|Gatalica, Zoran|Barrett, Michael T|Cridebring, Derek|Von Hoff, Daniel D | ||||||||||
| PMID: | 26380056 | ||||||||||
| 7. | |||||||||||
| Journal: | J Gastrointest Oncol. 2016 Apr;7(2):E17-21. | ||||||||||
| Title: | Use of molecular studies for treatment of metastatic pleomorphic large cell pancreatic cancers-a novel strategy. | ||||||||||
| Author: | Padhi, Parikshit|Narula, Arshjyot|Balog, Anna|Christou, Antonios | ||||||||||
| PMID: | 27034802 | ||||||||||
| 8. | |||||||||||
| Journal: | PLoS One. 2017 Jan 4;12(1):e0169335. | ||||||||||
| Title: | The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways. | ||||||||||
| Author: | Youns, Msmall a, Cyrillichmoud|Abdel Halim Hegazy, Wael | ||||||||||
| PMID: | 28052097 | ||||||||||
| 9. | |||||||||||
| Journal: | Int J Nanomedicine. 2017 Feb 7;12:1009-1018. | ||||||||||
| Title: | Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer. | ||||||||||
| Author: | Ludwig, Robert|Teran, Francisco J|Teichgraeber, Ulf|Hilger, Ingrid | ||||||||||
| PMID: | 28223795 | ||||||||||
| 10. | |||||||||||
| Journal: | Gene. 2017 Aug 20;625:72-77. | ||||||||||
| Title: | Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors. | ||||||||||
| Author: | Zhou, Huaqiang|Chen, Qinchang|Tan, Wulin|Qiu, Zeting|Li, Si|Song, Yiyan|Gao, Shaowei | ||||||||||
| PMID: | 28479381 | ||||||||||
| 11. | |||||||||||
| Journal: | Eur J Cancer. 2017 Sep;83:80-87. | ||||||||||
| Title: | Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients. | ||||||||||
| Author: | Heestand, Gregory M|Schwaederle, Maria|Gatalica, Zoran|Arguello, David|Kurzrock, Razelle | ||||||||||
| PMID: | 28728050 | ||||||||||
| 12. | |||||||||||
| Journal: | Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):197-207. | ||||||||||
| Title: | TOP2A induces malignant character of pancreatic cancer through activating beta-catenin signaling pathway. | ||||||||||
| Author: | Pei, Yao-Fei|Yin, Xi-Min|Liu, Xi-Qiang | ||||||||||
| PMID: | 29045811 | ||||||||||
| 13. | |||||||||||
| Journal: | Naunyn Schmiedebergs Arch Pharmacol. 2018 May;391(5):551-560. | ||||||||||
| Title: | The growth inhibitory effect of gambogic acid on pancreatic cancer cells. | ||||||||||
| Author: | Youns, Msmall a, Cyrillichmoud|ElKhoely, Abeer|Kamel, Rehab | ||||||||||
| PMID: | 29546614 | ||||||||||